Estimated reading time: 1 minutes
A researcher is developing a patent-pending platform technology called LENN that mimics the dual-layer structure of viruses to deliver nucleic acid (NA)-based therapies to targeted cancer cells.
About The Author
Discover more from Life is Pro-Mazing!
Subscribe to get the latest posts sent to your email.